- Company
- Lioresal Intrathecal can be prescribed in general hospitals
- by Eo, Yun-Ho Oct 16, 2023 05:24am
- The skeletal muscle relaxant and antispastic ‘Lioresal Intrathecal (baclofen injection)’ may now be prescribed in general hospitals in Korea According to industry sources, Novartis' Lioresal (baclofen), which will be supplied through the Korea Orphan & Essential Drug Center, has passed the Drug Committees (DCs) of tertiary hospitals inc
- Company
- Record number of reimbursed drugs listed in 1 yr
- by Chon, Seung-Hyun Oct 16, 2023 05:24am
- The number of drugs listed for health insurance reimbursement reached a record high in one year. After the generic market for the diabetes treatment drug ‘Januvia’ opened up, the number of reimbursed drugs expanded rapidly. With single-agent and combination-drug generics of Januvia that were approved under consignment contracts signed before t
- Company
- Will Paxlovid open a market for elderly people’s benefits?
- by Eo, Yun-Ho Oct 16, 2023 05:24am
- As the sense of crisis regarding COVID-19 infection is decreasing, attention is being paid to whether Paxlovid, a treatment drug, can successfully be registered for insurance benefits. Pfizer Korea is currently proceeding with the registration process for Paxlovid, which has been approved as an oral treatment for COVID-19, with the goal of l
- Policy
- Regkirona approval is for the Moon care to build up records
- by Lee, Jeong-Hwan Oct 13, 2023 05:30am
- People Power Party lawmaker Lee Jong-seong pointed out the Moon Jae-in government's budget support for Celltrion's COVID-19 treatment Regkirona as a problem. Rep. Lee Jong-seong criticized the approval of Regkirona, saying it lacked proper verification of effectiveness in order to build on the previous government's legacy of the K vaccine. O
- Policy
- NA Rep Kang ‘Increase gov't support to treat breast cancer'
- by Lee, Jeong-Hwan Oct 13, 2023 05:29am
- It has been pointed out that the government should strengthen economic support for innovative new drugs that treat severe diseases to improve the treatment rate of breast cancer patients. The number of female cancer patients is significantly higher than that of male cancer patients in the same age group, and the number of breast cancer
- Company
- Bayer Korea appoints JinA Lee as new Managing Director
- by Eo, Yun-Ho Oct 13, 2023 05:29am
- Bayer Korea appointed JinA Lee (54) as the new Managing Director. With this appointment, Lee will become the first Korean head to be appointed to the establishment of Bayer Korea. The company recently announced through an internal announcement that it will appoint JinA Lee, former CDH (Country Division Head) of Pharmaceuticals and Managin
- Policy
- The fate of the drugs identified in the inspeciton inspectio
- by Lee, Tak-Sun Oct 13, 2023 05:29am
- Specifically, they are breast cancer treatment Enhertu, Parkinson's disease treatment Madopar, and other immunotherapy drugs. Enhertu was mentioned by People Power Party lawmaker Kang Ki-yoon. He said that the number of female cancer patients is rapidly increasing and ordered coverage of expensive innovative treatments. At this point, Enh
- Policy
- Reimb extensions for Keytruda to be rediscussed later
- by Lee, Tak-Sun Oct 13, 2023 05:29am
- MSD Korea's immunotherapy drug 'Keytruda (pembrolizumab)', which applied for a large-scale reimbursement extension, was unable to pass the first hurdle and was determined in need of rediscussions. The authorities plan to first receive the pharmaceutical company's financial sharing plan and then decide whether to set a reimbursement stand
- Company
- Companies entering the Middle East caught in the crossfire
- by Kim, Jin-Gu Oct 12, 2023 05:38am
- On the 7th (local time), the Palestinian armed political faction Hamas attacked Israel (CNN photo). As the situation in Israel and nearby regions has deteriorated rapidly due to large-scale airstrikes by the Palestinian armed political faction Hamas, domestic pharmaceutical and bio companies that have entered or are seeking to enter the Midd
- Company
- Bukwang Pharm’s Ozanex lands in major general hospitals
- by Nho, Byung Chul Oct 12, 2023 05:37am
- Bukwang Pharm announced that its new topical antibiotic Ozanex cream(ozenoxacin)’ recently passed the drug committee of Seoul St.Mary’s Hospital and can be prescribed in major general hospitals in Korea. Ozanex, a topical antibiotic that Bukwang was first to introduce to Korea, is currently being prescribed at various major general hosp
